Zucker School of Medicine at Hofstra/Northwell (North Shore University Hospital/LIJ)
Rheumatology fellowship · Manhasset, NY · Program website
- 13
- Faculty
- 3
- Trainees
- 231
- Papers
- 0%
- Trainees published
- —
- First author
2 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 231 in all. Updated 2026-11-06.
- Disarming FcR-dependent neutrophil activation in MPO-ANCA glomerulonephritisAnne Davidson · The Journal of Experimental Medicine · 2026 · PubMed
- The neuropsychiatric systemic lupus erythematosus biomarker landscape: what blood and cerebrospinal fluid analytes have been studied and how they performed? A systematic review and meta-analysisCarolina Muñoz‐Grajales et al. · Frontiers in Immunology · 2026 · PubMed
- IgG4 ‐to‐ IgG Ratio and Orbital Involvement Predict Clinical Response to B Cell Depletion in IgG4 ‐Related DiseaseYoung Min Cho et al. · ACR Open Rheumatology · 2026 · PubMed
- ERN ReCONNET–SLICC–SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)Laurent Arnaud et al. · The Lancet Rheumatology · 2026 · PubMed
- Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case seriesIvana Ilić et al. · Rheumatology · 2026 · PubMed
- Pre-vaccine sentinel antibodies predict blunted vaccine responsesLusheng Song et al. · Cell Press Blue · 2026 · PubMed
- A population-scale transcriptional atlas of blood and tissue in lupus nephritisNicholas W. Sugiarto et al. · Science Translational Medicine · 2026 · PubMed · cited 6
- The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction PhasesBurak Kundakci et al. · Arthritis Care & Research · 2026 · PubMed
- Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritisChirag Raparia et al. · Annals of the Rheumatic Diseases · 2026 · PubMed · cited 3
- The lupus damage index revision program: Results from the item generation and reduction phasesBurak Kundakci et al. · Lupus Science & Medicine · 2026 · PubMed · cited 1
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 0 of 3 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
0%
of trainees have published
18th of 31 rheumatology fellowship programs with complete rosters
0
papers per trainee-year
18th of 31 rheumatology fellowship programs with complete rosters
—
of authorships as 1st author
0
papers with a trainee author
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
11 / 13
faculty matched
21 (9–64)
faculty h-index, median (IQR)
2.24
median FWCI (before 2025)
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Betty Diamond, MD | Systemic Lupus Erythematosus Research; Pulmonary Hypertension Research and Treatments | 86 | 62 | 2 | 20 | 1.87 |
| Cynthia Beth Aranow, MD | Systemic Lupus Erythematosus Research; Telemedicine and Telehealth Implementation | 73 | 52 | 2 | 1 | 1.66 |
| Richard A. Furie, MD | Systemic Lupus Erythematosus Research; CAR-T cell therapy research | 72 | 104 | 13 | 12 | 4.43 |
| Anne Davidson, MBBS | Systemic Lupus Erythematosus Research; SARS-CoV-2 and COVID-19 Research | 56 | 26 | 1 | 10 | 2.16 |
| Meggan Claire Mackay, MD | Systemic Lupus Erythematosus Research; Telemedicine and Telehealth Implementation | 49 | 32 | 1 | 3 | 2.21 |
| Sonali Narain, MD | Inflammatory Myopathies and Dermatomyositis; Systemic Lupus Erythematosus Research | 21 | 10 | 0 | 2 | 3.44 |
| Galina S. Marder, MD | Inflammatory Myopathies and Dermatomyositis; SARS-CoV-2 and COVID-19 Research | 15 | 11 | 1 | 4 | 3.07 |
| Maria-Louise Barilla-Labarca, MD | Inflammatory Myopathies and Dermatomyositis; Myasthenia Gravis and Thymoma | 11 | 2 | 0 | 0 | 1.7 |
| Lara El Khoury, MD | Vasculitis and related conditions; Systemic Lupus Erythematosus Research | 7 | 5 | 0 | 1 | 6.39 |
| Julie Schwartzman-Morris, MD | Innovations in Medical Education | 5 | 1 | 0 | 0 | — |
| Elena Katzap, DO | Patient Satisfaction in Healthcare | 3 | 1 | 0 | 0 | — |
| Diane Michelle Horowitz, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Peter K. Gregersen, MD (unresolved) | — | — | 0 | 0 | 0 | — |
3 trainees are counted above but never listed by name.
About Donald & Barbara Zucker School of Medicine at Hofstra/Northwellinstitution-wide rheumatology research
Rheumatology publications from Donald & Barbara Zucker School of Medicine at Hofstra/Northwell + Northwell Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
75
works per year
9th of 60 rheumatology fellowship programs
+35.2%
2-year growth
13th of 60 rheumatology fellowship programs
30.0%
in top 10% of field (works before 2025)
4th of 54 rheumatology fellowship programs
46.3%
cited above world average
17th of 54 rheumatology fellowship programs
Works per year · * 2026 so far
Rheumatology · 375
Rheumatology research topics at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Papers in the window; each links to the list on OpenAlex.
- Systemic Lupus Erythematosus Research 217
- Osteoarthritis Treatment and Mechanisms 23
- Bone Tumor Diagnosis and Treatments 21
- Pelvic floor disorders treatments 20
- Rheumatoid Arthritis Research and Therapies 15
- Soft tissue tumor case studies 13
- Spondyloarthritis Studies and Treatments 9
- Moyamoya disease diagnosis and treatment 9
Most cited at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell since 2024
All rheumatology papers there on OpenAlex
- Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard Alan Furie et al. · New England Journal of Medicine · 2025 · PubMed · cited 284
- 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus NephritisLisa R. Sammaritano et al. · Arthritis & Rheumatology · 2025 · PubMed · cited 147
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 updateAntonis Fanouriakis et al. · Annals of the Rheumatic Diseases · 2025 · PubMed · cited 127
- Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupusCalvin Law et al. · Nature · 2024 · PubMed · cited 100
- Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synoviumGarrett S. Dunlap et al. · Nature Communications · 2024 · PubMed · cited 91
- Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trialsTina Baker et al. · Annals of the Rheumatic Diseases · 2024 · PubMed · cited 83
- Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritisAndrea Fava et al. · JCI Insight · 2024 · PubMed · cited 70
- 2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus ErythematosusLisa R. Sammaritano et al. · Arthritis Care & Research · 2025 · PubMed · cited 67
- Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE studyCynthia B. Aranow et al. · Annals of the Rheumatic Diseases · 2024 · PubMed · cited 63
- 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus NephritisLisa R. Sammaritano et al. · Arthritis Care & Research · 2025 · PubMed · cited 61